We conclude that in B16 melanoma cells PCSK9 enhances the degradation of LRP-1, and that the machinery to sort the [LDLR.PCSK9] and [LRP-1.PCSK9] complexes towards degradation compartments in B16F1 cells must be different. The gene discussed is LDLR; the disease is melanoma.